Adverse events are reported to Hong by the PI or research nurses working on the study. Adverse events can include skin toxicity, diarrhea, vomiting, and fatigue and are assessed using Common Terminology Criteria for Adverse Events (CTCAE). This helps grade the severity of the event and attribute the causality to the study drug. Hong then captures these within the patient's EDC.
Hong is also responsible for gathering information on prospective patients. She makes a report of the patient's relevant eligibility criteria and based on her information, the PI decides whether or not the patient is a good fit for a particular clinical trial. "Even though I do not have direct patient contact, it is rewarding to know that I am a part of getting them on a trial in the hopes for a better quality of life. Often times they come to Yale because they have exhausted all other options of standard treatment," said Hong.
For Hong, capturing patient data is not as easy as entering A, B, and C. There is a lot of research involved and she has to go through all of the PI's notes from meeting with patients, and sometimes years of medical history to find what she needs. Kathleen Uscinski, Associate Director for Clinical Trials Operations, commented, "Hong does an exceptional job representing the best face of Yale research. She consistently works to the highest standards and contributes to the overall mission of Yale Cancer Center by bringing excellence to the research enterprise."